Internal Medicine Doctors in Portland, IN Accepting Medicare

2 Internal Medicine doctors found. Showing 1 - 2

Brandon M Mansoor, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 W Votaw St, Portland, IN 47371 Phone: 260-726-1821

Dr. Joseph Francis Vormohr, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 430 W Votaw St, Portland, IN 47371 Phone: 607-267-6162    Fax: 260-726-8165

News Archive

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

U.S. taxpayers bear 60% of the cost of smoking-related diseases, study finds

Cigarette smoking generates as much as $170 billion in annual health care spending in the United States, according to a new study co-authored by researchers at Georgia State University's School of Public Health, the Centers for Disease Control and Prevention and RTI International.

Critical Diagnostics' Presage ST2 Assay effectively risk-stratifies chronic heart failure patients

Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.

ALLOZYNE signs worldwide, co-exclusive licensing agreement with Sigma-Aldrich

ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.

Researchers disprove previously assumed behavior of macrophage immune cells

What happens when macrophage immune cells are activated in the course of an inflammation to combat pathogens such as bacteria or viruses? Researchers of the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg pursued this very question. The researchers discovered that the immune cells behave differently from what was previously assumed. Their metabolism upholds the production of antimicrobial substances and fatty acids during activation. In this way, they deliver important resources for the immune responses they trigger.

Read more Medical News

› Verified 5 days ago